Pathogenic or likely pathogenic DES variants were associated with a 57.4% incidence of major adverse cardiac events, with male patients facing a higher risk of sustained ventricular arrhythmias (HR 2.28).
Meta-Analysis (n=230)
DES cardiomyopathy is characterized by high familial penetrance, heterogeneous phenotypes, and a substantial MACE burden, with male patients facing a higher risk of sustained ventricular arrhythmias and heart failure events.
BACKGROUND: Pathogenic/likely pathogenic (LP) desmin ( DES ) variants cause heterogeneous cardiomyopathy and skeletal myopathy phenotypes. Limited data suggest a high incidence of major adverse cardiac events (MACEs), including cardiac conduction disease, sustained ventricular arrhythmias (VA), and heart failure (HF) events (HF hospitalization, left ventricular assist device/cardiac transplant, HF-related death) in patients with pathogenic/LP DES variants. However, pleiotropic presentation and small cohort sizes have limited clinical phenotype and outcome characterization. We aimed to describe the natural history, phenotype spectrum, familial penetrance and outcomes in patients with pathogenic/LP DES variants through a systematic review and individual patient data meta-analysis using published reports. METHODS: We searched Medline (PubMed) and Embase for studies that evaluated cardiac phenotypes in patients with pathogenic/LP DES variants. Cardiomyopathy diagnosis or occurrence of MACE was considered evidence of cardiac involvement/penetrance. Lifetime event-free survival from cardiac conduction disease, sustained VA, HF events, and composite MACE was assessed. RESULTS: Of the 4212 screened publications, 71 met the inclusion criteria. A total of 230 patients were included (52.6% men, 52.2% probands, median age: 31 years 22.0–42.8 at first evaluation, median follow-up: 3 years 0–11.0). Overall, 124 (53.9%) patients were diagnosed with cardiomyopathy, predominantly dilated cardiomyopathy (14.8%), followed by restrictive cardiomyopathy (13.5%), whereas other forms were less common: arrhythmogenic cardiomyopathy (7.0%), hypertrophic cardiomyopathy (6.1%), arrhythmogenic right ventricular cardiomyopathy (5.2%), and other forms (7.4%). Overall, 132 (57.4%) patients developed MACE, with 96 (41.7%) having cardiac conduction disease, 36 (15.7%) sustained VA, and 43 (18.7%) HF events. Familial penetrance of cardiac disease was 63.6% among relatives with pathogenic/LP DES variants. Male sex was associated with an increased risk of sustained VA (hazard ratio, 2.28; P =0.02) and HF events (hazard ratio, 2.45; P =0.008). CONCLUSIONS: DES cardiomyopathy exhibits heterogeneous phenotypes and a distinct natural history, characterized by high familial penetrance and a substantial MACE burden. Male patients face a higher risk of sustained VA events.
Asatryan et al. (Wed,) conducted a meta-analysis in Desmin (DES)-Associated Cardiomyopathy (n=230). Pathogenic or likely pathogenic (P/LP) DES variants was evaluated on Major adverse cardiac events (MACE). Pathogenic or likely pathogenic DES variants were associated with a 57.4% incidence of major adverse cardiac events, with male patients facing a higher risk of sustained ventricular arrhythmias (HR 2.28).